Detalhe da pesquisa
1.
Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone.
J Virol
; 91(1)2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795432
2.
Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone".
J Virol
; 91(8)2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356496
3.
Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model.
Virology
; 515: 235-242, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310105
4.
The FDA-approved drug sofosbuvir inhibits Zika virus infection.
Antiviral Res
; 137: 134-140, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27902933
5.
A sensitive DNA capacitive biosensor using interdigitated electrodes.
Biosens Bioelectron
; 87: 646-653, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619528
6.
Modeling HIV-1 Mucosal Transmission and Prevention in Humanized Mice.
Methods Mol Biol
; 1354: 203-20, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714714
7.
Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.
Virology
; 489: 173-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771889
8.
HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.
Virology
; 464-465: 253-263, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25105490
9.
Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model.
Virology
; 432(2): 505-10, 2012 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22832125